CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer

Beuy Joob

Abstract


Dear Editor, We read the publication on “Association of CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer in Mazandaran Province, Northern Iran: A Case–control Study” with a great interest.[1] Khalili‑Tanha et al. concluded that “M2 allelic genotypes were significantly associated neither with breast cancer risk nor with clinicopathological characteristics in Mazandaran province. [1]” Indeed, the result from this study is concordant with a recent report from China.

Keywords


CYP1A1 M2; Polymorphism; Breast Neoplasms

Full Text:

PDF

References


Khalili‑Tanha G, Barzegar A, Nikbakhsh N, Ansari‑Pirsaraei Z.

Association of CYP1A1 M2 (A2455G) polymorphism with

susceptibility to breast cancer in Mazandaran province, Northern

Iran: A case–control study. Int J Prev Med 2019;10:92.

Wu H, Ouyang Q, Tian C, Xie N, Cao M, Shui ZR. Cytochrome

P450 1A1 (CYP1A1) gene polymorphisms and susceptibility to

breast cancer: A meta‑analysis in the Chinese population. Clin

Lab 2017;63:67‑72.

Kawajiri K, Fujii‑Kuriyama Y. P450 and human cancer. Jpn J

Cancer Res 1991;82:1325‑35.